How one startup plans to disrupt the $423 billion pharmacy benefits manager market

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 51%

España Noticias Noticias

España Últimas Noticias,España Titulares

Capital Rx could turn the PBM industry on its head with a new model that illuminates the opaque drug pricing negotiation process:

in funding — has its work cut out as it sets out for new clients, but we think its disruptive approach positions the startup for success.Capital Rx is setting its new pricing model afloat in a convoluted PBM market rife with headaches for payer clients.

Long-standing PBMs have been placed under the government's microscope for controversial pricing strategies — some of which could be draining payers' pockets. PBMs have in the crosshairs of the US government's mission to deflate astronomical drug costs over the last couple of years.in July on a proposed rebate rule that could have significantly cut PBMs' margins, it's likely scrutiny of PBMs won't let up entirely — from not only the government, but also the independent payers they contract with, which could be losing cash as PBMs take a larger cut from the sum they reel in from drugmakers.

But Capital Rx is looking to shine a light on the opacity of PBMs: It wants to boost cost transparency and consistency for its clients by using the government-maintained National Average Drug Acquisition Cost database, which aims to provide accurate, upfront costs of drugs across pharmacies to health plans.Though deeply entrenched, the PBM space is primed for disruption — and it's likely independent payers will embrace new players catalyzing the changes.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 729. in ES
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Hydrogen Truck Startup Nikola's Valuation Jumps To $3 Billion With Investment From CNH IndustrialThe $250 million investment from the European maker of heavy-duty work vehicles represents a quarter of Nikola’s $1 billion funding goal. Why name your HYDROGEN truck startup after Tesla? Wow
Fuente: Forbes - 🏆 394. / 53 Leer más »

U.S. judge orders big drug companies to face opioid trialA U.S. judge on Tuesday rejected efforts by major drugmakers, pharmacies and dis... I hope they pay for their share of responsibility. Doctors overprescribing them should go next. The Saclkers sent too much money to Israel to be be even a little worried about this. Healthcare and drugs are among the most regulated industries. Going to go after the federal government for its role in the crisis?-regulations and the ‘war on drugs’ contributions as well.
Fuente: Reuters - 🏆 2. / 97 Leer más »